We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Guideline: ADHD Trials Require Comparator and Placebo Arms
Guideline: ADHD Trials Require Comparator and Placebo Arms
February 4, 2009
Sponsors of investigational drugs for attention deficit hyperactivity disorder (ADHD) should conduct short-term clinical trials with a placebo and a comparator arm, the European Medicines Agency (EMEA) says in a draft guideline.